| Association of gender, diagnosis, and obesity with retention rate of secukinumab in spondyloarthropathies: results form a multicenter real-world study A García-Dorta, P León-Suarez, S Peña, M Hernández-Díaz, ... Frontiers in Medicine 8, 815881, 2022 | 12 | 2022 |
| Beta-cell function is disrupted in patients with systemic lupus erythematosus A García-Dorta, JC Quevedo-Abeledo, Í Rua-Figueroa, ... Rheumatology 60 (8), 3826-3833, 2021 | 11 | 2021 |
| The number of traditional cardiovascular risk factors is independently correlated with disease activity in patients with psoriatic arthritis I Ferraz-Amaro, D Prieto-Peña, N Palmou-Fontana, D Martínez-López, ... Medicina 56 (8), 415, 2020 | 10 | 2020 |
| Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study JM Álvaro-Gracia, C Sanchez-Piedra, D Culqui, R Rosello, ... RMD open 9 (1), e002936, 2023 | 6 | 2023 |
| Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review D Prieto-Peña, JG Ocejo-Vinyals, J Mazariegos-Cano, AL Pelayo-Negro, ... European Journal of Internal Medicine 101, 86-92, 2022 | 5 | 2022 |
| Baseline levels of vitamin D in a healthy population from a region with high solar irradiation A García-Dorta, L Medina-Vega, JJ Villacampa-Jiménez, ... Nutrients 13 (5), 1647, 2021 | 3 | 2021 |
| Early identification of golimumab-treated patients with higher likelihood of long-term retention A García-Dorta, E González-Dávila, M Sánchez-Jareño, L Cea-Calvo, ... Frontiers in Immunology 15, 1359571, 2024 | | 2024 |
| Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry J Calvo-Gutiérrez, C López-Medina, L Otero-Varela, ... Arthritis Research & Therapy 26 (1), 57, 2024 | | 2024 |
| Glucocorticoid Use in Rheumatoid Arthritis Patients Initiating Biological or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (b/tsDMARDs) in Real Life: Data from … L Otero-Valera, JM Alvaro-Gracias, J Calvo, C Campos, A Garcia Dorta, ... ARTHRITIS & RHEUMATOLOGY 75, 866-868, 2023 | | 2023 |
| POS1073 IMPACT OF COMORBIDITIES ON THE FIRST BDMARD EFFECTIVENESS AND RETENTION RATE AFTER 2 YEARS OF FOLLOW-UP IN PATIENTS WITH RHEUMATOID ARTHRITIS. DATA FROM THE SPANISH … J Calvo Gutierrez, C López-Medina, L Otero-Varela, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 858-859, 2023 | | 2023 |
| SAT0076 VERY ELDERLY ONSET RHEUMATOID ARTHRITIS (VEORA): CLINICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS AG Dorta, C Almeida, HD Marta, LC Martín, E Trujillo, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 972-973, 2020 | | 2020 |
| THU0136 VERY ELDERLY ONSET RHEUMATOID ARTHRITIS (VEORA): CLINICAL AND THERAPEUTIC IMPLICATIONS AFTER 80 YEARS AG Dorta, C Almeida, HD Marta, LC Martín, E Trujillo, I Ferraz-Amaro, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 283-284, 2020 | | 2020 |
| AB1315 MIOSITIS AUTOANTIBODIES PROFILE: DIAGNOSTIC RELEVANCE AG Dorta, Y Barrios, SP Montelongo, HD Marta, AM Calero, BR Lozano, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 2120-2121, 2019 | | 2019 |
| THU0233 ASSOCIATION BETWEEN DEMYELINATING DISEASE AND AUTOINMMUNE RHEUMATIC DISEASE. A MULTIDISCIPLINARY EVALUATION SP Montelongo, GP Montserrat, AG Dorta, HD Marta, S Bustabad, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 394-394, 2019 | | 2019 |
